Science news and articles on health, environment, global warming, stem cells, bird flu, autism, nanotechnology, dinosaurs, evolution -- the latest discoveries in astronomy, anthropology, biology, chemistry, climate & bioengineering, computers, engineering ; medicine, math, physics, psychology, technology, and more from the world's leading research centers universities.

Local drug activation at solid tumor sites

0
IMAGE

Credit: TJ Grant

Sarcoma is an aggressive form of cancer responsible for up to 20 percent of childhood cancers. Tumors often first appear in the extremities and the abdomen. Surgery is a primary treatment, but it often is combined with chemotherapy. This week in ACS Central Science, researchers propose a scheme to target chemotherapy medications specifically to sarcomas, leading to greater efficacy and fewer side effects.

Jose Mejia Oneto, Max Royzen and colleagues developed a technology that shields a toxic and commonly-used chemotherapeutic, doxorubicin, until it comes into contact with an activating agent held at the tumor site by a polymer material. While both the traditional delivery of doxorubicin and the new approach were successful in the initial treatment of sarcoma tumors in mice, only the site-activated drug kept the cancer from coming back. In addition to a better therapeutic outcome, the local activation strategy had fewer side effects. In particular, the researchers did not observe a decrease in new red blood cells, a marker of bone marrow suppression which limits the tolerable dose in patients. Other unpleasant side effects such as weight loss or changes in hair were not observed compared to those treated conventionally. The authors intend to leverage the lower toxicity of their treatment to investigate whether shorter courses of their therapy using higher doses are even more effective and expand this approach to other solid tumors and drugs.

###

The authors acknowledge funding from the National Science Foundation, State University of New York at Albany and Shasqi.

The paper will be freely available on July 13th, at this link: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00150

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With nearly 157,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected]

Follow us: Twitter Facebook

Media Contact

Michael Bernstein
[email protected]
202-872-6042
@ACSpressroom

http://www.acs.org

Leave A Reply

Your email address will not be published.